Education
About Us
Working with TipRanks
Follow Us
Jeffrey J Scherman Insider Profile
4 Followers
Jeffrey J Scherman, CAO at NeueHealth Inc, holds 0.00 shares in NeueHealth Inc (Ticker: NEUE).
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+33.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Jeffrey J Scherman does not currently own shares as a corporate insider.
A breakdown of Jeffrey J Scherman's holdings
Insider Roles
Jeffrey J Scherman does not currently hold a role as a corporate insider.
Roles that Jeffrey J Scherman holds in companies
Most Profitable Insider Trade
Stock:
NeueHealth Inc
(NEUE)
(NEUE)
Rating:Informative Sell
Date:Mar 15, 2023 - Mar 15, 2024
Return:+73.70%
The most profitable trade made by Jeffrey J Scherman
Jeffrey J Scherman's Trading History
List of latest transactions for each holding click on a transaction to see Jeffrey J Scherman's performance on stock
You May Also Like
Jeffrey J Scherman insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey J Scherman?
The percentage of profitable transactions made by Jeffrey J Scherman is 100%.
What is the average return per transaction made by Jeffrey J Scherman?
The average return per transaction made by Jeffrey J Scherman is 33.70%.
What stocks does Jeffrey J Scherman hold?
Jeffrey J Scherman holds: NEUE stocks.
What was Jeffrey J Scherman’s latest transaction?
Jeffrey J Scherman latest transaction was an Uninformative Sell of $91.35K.
What was Jeffrey J Scherman's most profitable transaction?
Jeffrey J Scherman’s most profitable transaction was an Informative Sell of NEUE stock on March 15, 2023. The return on the trade was 73.70%.
What is Jeffrey J Scherman's role in NeueHealth Inc?
Jeffrey J Scherman's role in NeueHealth Inc is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.